GUTS · Fractyl Health, Inc. · Executive Compensation
$0.43
-0.02 (-4.02%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we have concluded that substantial doubt exists about our ability to continue as a going concern for at least one year after the date that these financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$77.30M
Shares
159.18M
Volume · Oct 1
5.55M
Avg daily vol (3M)
1.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Harith Rajagopalan | M.D., Ph.D. Chief Executive Officer | $6,414,290 |
| Jay D. Caplan | President and Chief Product Officer | $3,043,034 |
| Sarah Toomey | General Counsel and Corporate Secretary | $2,445,850 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Harith Rajagopalan | M.D., Ph.D. Chief Executive Officer | $4,856,361 |
| Jay D. Caplan | President and Chief Product Officer | $2,198,612 |
| Lisa Davidson | Chief Financial Officer and Treasurer | $1,972,272 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Harith Rajagopalan | M.D., Ph.D. Chief Executive Officer | $3,561,774 |
| Jay D. Caplan | President and Chief Product Officer | $2,873,373 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lisa Davidson | Chief Financial Officer | Resigned | 2026-01-06 |
| Lara Smith Weber | Chief Financial Officer | Appointed | 2026-01-06 |
| Amy W. Schulman | Class I director | Resigned | 2025-09-03 |
| Ian Sheffield | Class II director | Appointed | 2025-09-03 |
| Christopher Thompson, M.D. | Class I director | Appointed | 2025-09-03 |